sponsored
The role of the GP in treatment-refractory schizophrenia: case study
A typical shared care prescribing arrangement
This content has been independently produced by ADG, made possible through sponsorship from Viatris
Introduction
Poor response to antipsychotics remains a major challenge for clinicians managing schizophrenia. Treatment-refractory illness occurs in about 20 -40% of all patients with schizophrenia. Only one pharmacological agent
